361 Capital’s Arrowhead Research ARWR Stock Holding History

361 Capital’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-161,839	Closed	-$2.97M	–	316
2019 Q1	$2.97M	Sell	161,839 -36,706	-18%	-$605K	0.52%	49
2018 Q4	$2.47M	Buy	+198,545	New	+$2.71M	0.5%	49

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

361 Capital's ARWR Position: Q2 2019 in Review

361 Capital sold out of Arrowhead Research (ARWR) in Q2 2019, closing a stake of 161,839 shares — an estimated $2.97M sold.

361 Capital first reported a position in ARWR in Q4 2018 and held it in 2 quarters. The position peaked at $2.97M in Q1 2019. 212 funds tracked by Wall St. Rank hold ARWR as of Q2 2019.

361 Capital reported no remaining Arrowhead Research position as of Q2 2019 after selling out during the quarter.
361 Capital sold 161,839 Arrowhead Research shares in Q2 2019, an estimated $2.97M.
361 Capital first reported a position in Arrowhead Research in Q4 2018 and held it in 2 quarters.
361 Capital's Arrowhead Research position peaked at $2.97M in Q1 2019.
212 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2019.

Based on 361 Capital's 13F filing for Q2 2019, filed 7 Aug 2019.